SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem

Instituto Costarricense de Investigaciones Clínicas ICIC

Status: Withdrawn

Conditions: COVID19

Treatments: Diagnostic Test: Breath sample

Study type: Observational

Funder types: Other

Identifiers

NCT04497610

Tera-CR-1

Details and patient eligibility

About

The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.

Full description

BioSafety Technologies has developed a rapid detection test to clear people of COVID-19.

A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel.

The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.

Sex: All

Ages: 7+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Older than 7 years odf age Able to provide informed consent Able to take the breath test

Exclusion criteria

Younger than 7 years of age Unable to provide informed consent Unable to take the breath test

Trial design

0 participants in 2 patient groups

Positive TeraSystem test

Description:

Patients having positive PCR tests will undergo TeraSystem test

Treatment:

Diagnostic Test: Breath sample

Negative TeraSystem test

Description:

Patients having negative PCR tests will undergo TeraSystem test

Treatment:

Diagnostic Test: Breath sample